Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 1,741,431 | 1,127,141 | 569,001 | 2,311,925 | 1,716,486 |
| Accounts payable and accrued liabilities | -1,406,427 | -959,300 | -509,683 | -1,818,575 | -1,392,653 |
| Other Working Capital | 272,399 | 146,989 | 54,559 | 425,939 | 269,818 |
| Other Operating Activity | -316,809 | -159,900 | -51,069 | -461,392 | -295,556 |
| Operating Cash Flow | $290,594 | $154,930 | $62,808 | $457,897 | $298,095 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 134,008 | 23,428 | 9,231 | -39,918 | -2,416 |
| PPE Investments | -59,634 | -39,674 | -21,553 | -98,403 | -76,849 |
| Net Acquisitions | -84,415 | -84,649 | N/A | -79,386 | -75,811 |
| Purchase Sale Intangibles | -100 | -100 | -100 | 8,818 | 7,383 |
| Other Investing Activity | -100 | -100 | -100 | 8,818 | 7,383 |
| Investing Cash Flow | $-10,141 | $-100,995 | $-12,422 | $-208,889 | $-147,693 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,780 | -1,597 | -1,415 | -643 | -487 |
| Common Stock Issued | -84,823 | 8,202 | 4,068 | 16,944 | 13,571 |
| Common Stock Repurchased | N/A | -100,005 | -100,005 | -28,000 | -20,000 |
| Other Financing Activity | -14,554 | -8,196 | -1,265 | -11,059 | -11,059 |
| Financing Cash Flow | $-101,157 | $-101,596 | $-98,617 | $-22,758 | $-17,975 |
| Exchange Rate Effect | 3,154 | -2,858 | -5,977 | 2,237 | -3,239 |
| Beginning Cash Position | 662,651 | 662,651 | 662,651 | 434,164 | 434,164 |
| End Cash Position | 845,101 | 612,132 | 608,443 | 662,651 | 563,352 |
| Net Cash Flow | $182,450 | $-50,519 | $-54,208 | $228,487 | $129,188 |
| Free Cash Flow | |||||
| Operating Cash Flow | 290,594 | 154,930 | 62,808 | 457,897 | 298,095 |
| Capital Expenditure | -59,685 | -39,707 | -21,591 | -98,532 | -76,934 |
| Free Cash Flow | 230,909 | 115,223 | 41,217 | 359,365 | 221,161 |